col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


53 Results       Page 1

 [1] 
Wiley: Phytotherapy Research
  original article Date Title Authors   All Authors
1 [GO] 2023―May―11 Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 ( SARS-CoV -2) binding to angiotensin-converting enzyme 2 Junjie Zhu, Huimin Yan, Mengyao Shi, Min Zhang, Jia Lu, Jiabao Wang, et al. (+5)
2 [GO] 2023―Apr―12 Validation of baicalein and oridonin as nonspecific SARS-CoV -2 main protease inhibitors Haohao Yan, Rui Zhang, Gangan Yan, Xiaoping Liu, Ni Li, Yunyu Chen
3 [GO] 2023―Feb―14 Multi-target approach against SARS-CoV -2 by stone apple molecules: A master key to drug design Rahul Singh, Rituraj Purohit
4 [GO] 2023―Jan―27 Kaempferol's potential effects against SARS-CoV -2 and COVID -19-associated cancer progression and chemo-resistance Hamidreza Zalpoor, Mahsa Liaghat, Maryam Bakhtiyari, Hooriyeh Shapourian, Abdullatif Akbari, Shaghayegh Shahveh, et al. (+3)
5 [GO] 2022―Nov―24 Phase III randomized clinical trial of BV -4051, an Ayurvedic polyherbal formulation in moderate SARS-CoV -2 infections and its impact on inflammatory biomarkers Deepa Chitre, Satej Nadkarni, Namdev Jagtap, Rahul Tulle, Amol Gitte, Prashant Rahate, et al. (+2)
6 [GO] 2022―Nov―22 Antcin A, a phytosterol regulates SARS-CoV -2 spike protein-mediated metabolic alteration in THP -1 cells explored by the 1 H-NMR -based metabolomics approach Gyaltsen Dakpa, Kanthasamy Jayabal Senthil Kumar, Nai-Wen Tsao, Sheng-Yang Wang
7 [GO] 2022―Nov―16 Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 ( COVID -19): A systematic review and meta-analysis of randomized controlled trials Di Jin, Jing Wang, Jiaojiao Xue, Yunyun Zhao, Guanchi Yan, Xiangyan Li, Xiuge Wang
8 [GO] 2022―Nov―07 Antiviral effects of phytochemicals against severe acute respiratory syndrome coronavirus 2 and their mechanisms of action: A review Ibrahim Jantan, Laiba Arshad, Abdi Wira Septama, Md. Areeful Haque, Zeti-Azura Mohamed-Hussein, Nisha T. Govender
9 [GO] 2022―Aug―09 Broad-spectrum antiviral activity of Spatholobus suberectus Dunn against SARS-CoV -2, SARS-CoV -1, H5N1 , and other enveloped viruses Qingqing Liu, Ka-Yi Kwan, Tianyu Cao, Bingpeng Yan, Kumar Ganesan, Lei Jia, et al. (+7)
10 [GO] 2022―Aug―08 Phytoncides could potentially inhibit the spike protein of SARS-CoV -2 variants Muruganantham Bharathi, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Subramanian Thangaleela, Chaiyavat Chaiyasut
11 [GO] 2022―Aug―06 Promising natural products against SARS-CoV -2: Structure, function, and clinical trials Yan Zhao, Shanshan Deng, Yujiao Bai, Jinlin Guo, Guoyin Kai, Xinhe Huang, Xu Jia
12 [GO] 2022―Aug―02 High-quality trials and pharmacological studies needed as translational evidence for the application of traditional Chinese medicine Lianhua Qingwen against COVID-19 Nan Huang, Saichao Li
13 [GO] 2022―Jul―21 Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19: A double-blind placebo-controlled clinical trial Hossein Aryan, Ramin Hamidi Farahani, Mohsen Chamanara, Sepideh Elyasi, Mahmoud Reza Jaafari, Mahboubeh Haddad, et al. (+3)
14 [GO] 2022―May―21 Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2 Rania Hamdy, Ahmed Mostafa, Noura M. Abo Shama, Sameh S. M. Soliman, Bahgat Fayed
15 [GO] 2022―Apr―09 In vitro antiviral activity against SARS-CoV -2 of common herbal medicinal extracts and their bioactive compounds Kristi Leka, Carla Hamann, Pauline Desdemoustier, Michel Frédérich, Mutien-Marie Garigliany, Allison Ledoux
16 [GO] 2022―Mar―31 Therapeutic potential of loureirin A against SARS-CoV -2 infection Mohammad Rafi Khezri, Donya Moloodsouri, Darya Hodaei, Morteza Ghasemnejad-Berenji
17 [GO] 2022―Mar―21 Quercetin potential effects against SARS-CoV -2 infection and COVID -19-associated cancer progression by inhibiting mTOR and hypoxia-inducible factor-1α ( HIF -1α) Hamidreza Zalpoor, Maryam Bakhtiyari, Mahsa Liaghat, Mohsen Nabi-Afjadi, Mazdak Ganjalikhani-Hakemi
18 [GO] 2022―Mar―01 Antiviral activity of plant juices and green tea against SARS-CoV -2 and influenza virus Maren Eggers, Peggy Jungke, Volker Wolkinger, Rudolf Bauer, Uwe Kessler, Bruno Frank
19 [GO] 2022―Jan―26 In vitro antiviral activity against SARS-CoV -2 of 28 Strychnos extracts Allison Ledoux, Kristi Leka, Olivier Bonnet, Aude Blanquer, Tiabou Tchinda Alembert, Patrick Silva Mirowski, et al. (+4)
20 [GO] 2022―Jan―18 Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial Ali Asadirad, Roohangiz Nashibi, Ali Khodadadi, Ata A Ghadiri, Mahvash Sadeghi, Azam Aminian, Sajad Dehnavi
21 [GO] 2022―Jan―13 Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial Elaheh Honarkar Shafie, Fateme Taheri, Neda Alijani, Ahmad Reza Okhovvat, Razieh Goudarzi, Nasrin Borumandnia, et al. (+4)
22 [GO] 2021―Dec―11 Plant cysteine proteases: Potential therapeutic agents against SARS-CoV -2 Filippe Elias de Freitas Soares, Mariana Aparecida de Freitas Abreu
23 [GO] 2021―Oct―26 Garcinia kola and garcinoic acid suppress SARS-CoV -2 spike glycoprotein S1 -induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation Olumayokun A Olajide, Victoria U Iwuanyanwu, Izabela Lepiarz-Raba, Alaa A Al-Hindawi, Mutalib A Aderogba, Hazel L Sharp, Robert J Nash
24 [GO] 2021―Oct―16 Cannabidiol inhibits SARS-Cov -2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ -dependent TLR4 / NLRP3 /Caspase-1 signaling suppression in Caco-2 cell line Chiara Corpetti, Alessandro Del Re, Luisa Seguella, Irene Palenca, Sara Rurgo, Barbara De Conno, et al. (+3)
25 [GO] 2021―Sep―02 Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome -CoV -2 viruses through blocking virus invasion and antiinflammatory effect Shaopeng Yu, Yao Chen, Yusen Xiang, He Lin, Mengge Wang, Wenbo Ye, et al. (+6)
26 [GO] 2021―Jul―13 Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease ( COVID -19), current evidence with systematic review and meta-analysis Fei Jiang, Nana Xu, Yanxi Zhou, Jinxing Song, Jinjuan Liu, Hong Zhu, et al. (+3)
27 [GO] 2021―Jun―16 Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review Rahul Soloman Singh, Ashutosh Singh, Harpinder Kaur, Gitika Batra, Phulen Sarma, Hardeep Kaur, et al. (+8)
28 [GO] 2021―Jun―11 Therapeutic targets of natural products for the management of cardiovascular symptoms of coronavirus disease 2019 Pardis Mohammadi Pour, Mohammad Hosein Farzaei, Ebrahim Soleiman Dehkordi, Anupam Bishayee, Sedigheh Asgary
29 [GO] 2021―Apr―16 The effect of propolis plus Hyoscyamus niger L. methanolic extract on clinical symptoms in patients with acute respiratory syndrome suspected to COVID -19: A clinical trial Morteza Kosari, Mehdi Noureddini, Seyed Peyman Khamechi, Ahmad Najafi, Amir Ghaderi, Mojtaba Sehat, Hamid Reza Banafshe
30 [GO] 2021―Apr―06 Silibinin as potential tool against SARS-Cov -2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, Francesco Cimino, Antonella Saija, Salvatore Vincenzo Giofrè
31 [GO] 2021―Apr―02 In silico approach of secondary metabolites from Brazilian herbal medicines to search for potential drugs against SARS-CoV -2 Tatiane R. Amparo, Janaína B. Seibert, Tamires C. Almeida, Fernanda S. F. Costa, Benila M. Silveira, Glenda N. Silva, et al. (+2)
32 [GO] 2021―Mar―31 Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV -2 Abhishek Gour, Diksha Manhas, Swarnendu Bag, Bapi Gorain, Utpal Nandi
33 [GO] 2021―Mar―24 Plant-derived chemicals as potential inhibitors of SARS-CoV -2 main protease ( 6LU7 ), a virtual screening study Mohsen Sisakht, Amir Mahmoodzadeh, Maryam Darabian
34 [GO] 2021―Feb―18 Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II /cell membrane chromatography Jiapan Gao, Yuanyuan Ding, Yuejin Wang, Peida Liang, Liyang Zhang, Rui Liu
35 [GO] 2021―Jan―15 In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV -2 main protease ( 3CLpro ) Abbas Khan, Wang Heng, Yanjing Wang, Jingfei Qiu, Xiaoyong Wei, Shaoliang Peng, et al. (+4)
36 [GO] 2021―Jan―03 Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease -19 patients: An open label nonrandomized clinical trial Niloofar Saber-Moghaddam, Soofia Salari, Sepideh Hejazi, Mahnaz Amini, Zhila Taherzadeh, Saeed Eslami, et al. (+3)
37 [GO] 2020―Dec―31 Phytotherapeutic options for the treatment of COVID-19: A concise viewpoint
38 [GO] 2020―Dec―22 Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses Mohamad H. Shahrajabian, Wenli Sun, Ali Soleymani, Qi Cheng
39 [GO] 2020―Nov―22 Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 ( SARS-CoV -2) in cultured Vero cells Minghui Yang, Jinli Wei, Ting Huang, Luping Lei, Chenguang Shen, Jinzhi Lai, et al. (+5)
40 [GO] 2020―Oct―09 A role for quercetin in coronavirus disease 2019 (COVID-19) Giuseppe Derosa, Pamela Maffioli, Angela D'Angelo, Francesco Di Pierro
41 [GO] 2020―Sep―28 Natural products for COVID -19 prevention and treatment regarding to previous coronavirus infections and novel studies Motahareh Boozari, Hossein Hosseinzadeh
42 [GO] 2020―Sep―24 The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV -2 targets Pratap Kumar Parida, Dipak Paul, Debamitra Chakravorty
43 [GO] 2020―Sep―23 Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV -2 drug targets: in vitro validation of furin inhibition I. Olaposi Omotuyi, Oyekanmi Nash, Basiru O. Ajiboye, Victor O. Olumekun, Babatunji E. Oyinloye, Oludare T. Osuntokun, et al. (+5)
44 [GO] 2020―Sep―18 Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID -19 ( SARS-CoV -2) William G. Lima, Júlio C. M. Brito, Waleska S. Cruz Nizer
45 [GO] 2020―Sep―15 Glycyrrhizin: An old weapon against a novel coronavirus Julian Chrzanowski, Alicja Chrzanowska, Wojciech Graboń
46 [GO] 2020―Aug―12 Traditional and complementary medicine during COVID -19 pandemic Shuvadeep Ganguly, Sameer Bakhshi
47 [GO] 2020―Aug―11 High affinity interaction of Solanum tuberosum and Brassica juncea residue smoke water compounds with proteins involved in coronavirus infection Gaurav S. Dave, Kalpna D. Rakholiya, Mital J. Kaneria, Bhemji P. Galvadiya, Sudhanshu R. Vyas, Vaktabhai H. Kanbi, Manubhai P. Patel
48 [GO] 2020―Aug―04 Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV -2 targeting its main protease Saurabh Upadhyay, Praveen K. Tripathi, Manju Singh, Siva Raghavendhar, Mohit Bhardwaj, Ashok K. Patel
49 [GO] 2020―Jul―02 Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19 Helda Tutunchi, Fatemeh Naeini, Alireza Ostadrahimi, Mohammad Javad Hosseinzadeh-Attar
50 [GO] 2020―Jun―26 Covid-19 and Thymoquinone: Connecting the Dots Ajaz Ahmad, Muneeb U Rehman, Parvaiz Ahmad, Khalid M. Alkharfy
51 [GO] 2020―May―29 Food as medicine: a possible preventive measure against coronavirus disease ( COVID -19) Yang Fan, Yue Zhang, Akash Tariq, Xiaolan Jiang, Zeeshan Ahamd, Zhang Zhihao, et al. (+4)
52 [GO] 2020―Apr―30 Phytotherapic compounds against coronaviruses: possible streams for future research Michele Antonelli, Davide Donelli, Valentina Maggini, Fabio Firenzuoli
53 [GO] 2020―Apr―05 Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data Muhammad Torequl Islam, Chandan Sarkar, Dina M. El-Kersh, Sarmin Jamaddar, Shaikh Jamal Uddin, Jamil A. Shilpi, Mohammad S. Mubarak
 [1] 

53 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.016 sec